Samples / OBX-319 / regulatory/m5-clinical/csr/CSR-102_MAD_synopsis.md

MAD Study Synopsis (OBX-319)

Document ID: CSR-102
Version: 1.0
Change History: 1.0 — Initial issue.
Standard(s): ICH E3

Supporting Study — MAD Synopsis — OBX-319

Synopsis of the multiple-ascending-dose study of OBX-319: repeat-dose safety, PK accumulation, and early pharmacodynamics informing the Phase 2/3 regimen.